Related Experiment Video
Updated: Jul 30, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Insulin acutely decreases hepatic fatty acid synthase activity
Sonia M Najjar1, Yan Yang, Mats A Fernström
1Department of Pharmacology, Cardiovascular Biology and Metabolic Diseases, The Medical University of Ohio, 3035 Arlington Avenue, HSci Building, Room 270, Toledo, OH 43614, USA. snajjar@meduohio.edu
Abstract:
Insulin is viewed as a positive regulator of fatty acid synthesis by increasing fatty acid synthase (FAS) mRNA transcription. We uncover a new mechanism by which insulin acutely reduces hepatic FAS activity by inducing phosphorylation of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and its interaction with FAS. Ceacam1 null mice (Cc1(-/-)) show loss of insulin's ability to acutely decrease hepatic FAS activity. Moreover, adenoviral delivery of wild-type, but not the phosphorylation-defective Ceacam1 mutant, restores the acute effect of insulin on FAS activity in Cc1(-/-) primary hepatocytes. Failure of insulin to acutely reduce hepatic FAS activity in hyperinsulinemic mice, including L-SACC1 transgenics with liver inactivation of CEACAM1, and Ob/Ob obese mice, suggests that the acute effect of insulin on FAS activity depends on the prior insulinemic state. We propose that this mechanism acts to reduce hepatic lipogenesis incurred by insulin pulses during refeeding.
Insights
Insulin acutely reduces liver fatty acid synthase (FAS) activity via CEACAM1 phosphorylation. This mechanism, dependent on prior insulin levels, regulates lipogenesis during refeeding.
Area of Science:
- Metabolism
- Molecular Biology
- Hepatology
Background:
- Insulin traditionally promotes fatty acid synthesis (FAS) by increasing FAS mRNA transcription.
- A novel mechanism for insulin's acute regulation of hepatic FAS activity is investigated.
Purpose of the Study:
- To elucidate a new pathway for insulin's rapid control of hepatic fatty acid synthase (FAS) activity.
- To determine the role of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in insulin signaling.
Main Methods:
- Utilized Ceacam1 null (Cc1(-/-)) mice and primary hepatocytes.
- Employed adenoviral delivery of wild-type and mutant CEACAM1.
- Examined insulin's effect on FAS activity in hyperinsulinemic and obese mouse models.
Main Results:
- Insulin acutely reduces hepatic FAS activity through CEACAM1 phosphorylation and interaction with FAS.
- Cc1(-/-) mice lack insulin's acute effect on hepatic FAS activity.
- Restoration of CEACAM1 function in Cc1(-/-) hepatocytes re-established insulin's acute effect.
Conclusions:
- CEACAM1-mediated phosphorylation is crucial for insulin's acute suppression of hepatic FAS activity.
- This pathway is essential for modulating hepatic lipogenesis in response to insulin pulses during refeeding.
- The acute effect of insulin on FAS activity is contingent upon the preceding insulinemic state.
Related Concept Videos
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Acute Pancreatitis II: Clinical Manifestations and Management
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...

